We are frequently faced with patients who require anticoagulation reversal due to hemorrhage or an emergent procedure. This has grown rather complicated, due to the emergence of numerous new anticoagulants and reversal agents. Furthermore, new evidence is emerging regarding the reversal of old agents (e.g. the PATCH trial regarding platelet transfusion in patients on aspirin). This chapter will strive to be a one-stop-shop where all this information is collected and updated (because it's humanly impossible to remember all this stuff).
The IBCC chapter is located here.
- The podcast & comments are below.
Follow us on iTunes
The Podcast Episode
Want to Download the Episode?
Right Click Here and Choose Save-As
Latest posts by Josh Farkas (see all)
- PulmCrit-The Rothman Index:Artificial intelligence or merely a symptom of a broken healthcare system? - January 25, 2020
- IBCC chapter & cast – Toxic Alcohols - January 23, 2020
- PulmCrit – An alternative view of the PEPTIC trial - January 22, 2020